Moderna, Inc. price

$241,08$0,00 (--)
Last updated on 12.11.2026 klo 22.51.33.
Market cap
$100,76 mrd.
Circulating supply
--
All-time high
$280,42
24h volume
$51 t.

Trusted by 100M+ globally

Find out why

About Moderna, Inc.

Moderna, Inc., bioteknologiayritys, on omistautunut lähetti-RNA:han (mRNA) perustuvien hoitojen ja ennaltaehkäisevien lääkkeiden löytämiseen, kehittämiseen ja kaupallistamiseen. Sen laaja tutkimus- ja kehityshanke kohdistuu laajaan kirjoon lääketieteellisiä tarpeita, mukaan lukien infektiotauti, syöpäimmunologia, harvinaiset sairaudet, sydän- ja verisuonisairaudet sekä autoimmuunisairaudet, ja toiminta kattaa Yhdysvallat, Euroopan ja muilla globaaleilla markkinoilla. Yhtiön monipuolinen tuoteputki kattaa erilaisia rokoteehdokkaita: hengitystiesairauksiin kuten COVID-19, influenssa ja hengitystiellinen synkytiaalinen virus (RSV); piilevät virusinfektiot kuten sytomegalovirus (CMV), Epstein-Barr-virus (EBV), ihmisen immuunikatovirus (HIV), herpes simplex virus (HSV) ja vesirokella-zostervirus (VZV); sekä kansanterveysuhkat kuten Zika ja Nipah. Lisäksi Moderna kehittää systeemisiä eritettyjä ja solupintaan kohdennettuja hoitomuotoja, erilaisia syöpärokotteita (mukaan lukien personoidut, KRAS- ja tarkistuspistelajit), kasvaimen sisäisiä immuno-onkologiatuotteita, paikallisia uudistavia hoitoja, systeemiset solunsisäiset lääkkeet sekä hengitettävät keuhkoratkaisut. Moderna ylläpitää strategisia yhteistyösuhteita useiden merkittävien tahojen kanssa, kuten AstraZeneca PLC:n, Merck & Co., Inc.:n, Vertex Pharmaceuticals Incorporatedin, Vertex Pharmaceuticals (Europe) Limitedin, Carisma Therapeutics, Inc.:n, Metagenomi, Inc.:n, Defense Advanced Research Projects Agencyn (DARPA), Biomedical Advanced Research and Development Authorityn (BARDA), Institute for Life Changing Medicinesin sekä Bill & Melinda Gates Foundationin. Yhtiöllä on myös yhteistyö- ja lisenssisopimus Chiesi Farmaceutici S.P.A:n kanssa. Yhtiö perustettiin vuonna 2010 nimellä Moderna Therapeutics, Inc., ja siitä tuli virallisesti Moderna, Inc. elokuussa 2018. Sen pääkonttori sijaitsee Cambridgessa, Massachusettsissa.

Osaketunnus
MRNA
Yritys
Moderna, Inc.
Teollisuus
Terveydenhuolto
Kategoria
US
Osakeanti / osakeyhdistäminen
--
Lanseerauspäivä
7.12.2018
Listattu pörssi
NASDAQ

Taloustiedot

Q3 FY2026 tulos
Raporttikausi: 1.7.2026 – 30.9.2026

Yhteenveto: MRNA reported Revenue of 1.31B (+29,23 %), beating expectations; EPS of 0,38 (+174,51 %), beating expectations.

Tulot (USD)Lyö1,31 mrd.+29,23 %890,25 milj.−3,33 %422,75 milj.+47,48 %
EPS (USD)Lyö0,38+174,50 %−-1,10+41,17 %1,48+134,54 %
Taloudelliset arviot
● Todellinen● Arvio
Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
−-0,51−-2,11−-3,40−-1,960,38
−1 664,42 %+27,49 %−34,93 %+7,98 %+174,50 %
● EPS● Vuosi vuodelta
Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
12,14 mrd.12,34 mrd.11,49 mrd.10,96 mrd.13,47 mrd.
2,81 mrd.3,69 mrd.4,08 mrd.4,20 mrd.6,63 mrd.
23,11 %29,89 %35,51 %38,31 %49,23 %
● Varat● Velat● Suhde
Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
−-847,00 milj.951,00 milj.−-630,00 milj.−-526,00 milj.−-1,56 mrd.
+45,91 %+15,27 %+39,24 %+42,76 %−84,07 %
● CFO● Vuosi vuodelta

Osakkeenomistajat

Osakkeenomistajat
FMR LLC13,09 %
BLACKROCK, INC.7,72 %
Stéphane Bancel7,57 %
VANGUARD CAPITAL MANAGEMENT LLC5,86 %
CAPITAL WORLD INVESTORS5,62 %
Muut60,11 %
Laitokset
% Omistettu81,92 %+3,92 %
Omistetut osakkeet323,61 milj.+15,51 milj.
Instituutiot862+63
% OmistettuHinta
Nimi% OmistettuVaihda
FMR LLC13,09 %+6,19 milj.
BLACKROCK, INC.7,72 %+963,53 t.
Stéphane Bancel7,57 %0,00
VANGUARD CAPITAL MANAGEMENT LLC5,86 %+336,33 t.
CAPITAL WORLD INVESTORS5,62 %+3,58 milj.
Trade on the go with the OKX app

Moderna, Inc.’s recent prices

Past year----
3 months----
30 days----
7 days−7,12 %$259,56

Moderna, Inc. performance

$241,08
Moderna, Inc. price today

Moderna, Inc. price today is $241,08, marking a -- over the past 24 hours. On OKX, today’s Moderna, Inc. trading volume reached 212,00, worth over $51 001,48.

$280,42
Moderna, Inc. all-time high

Moderna, Inc. achieved its all-time high price of $280,42 on 10.11.2026. At today’s price of $241,08, Moderna, Inc. price is now −14,03 % lower than its historic high.

$241,08
Moderna, Inc. in USD

The current Moderna, Inc. to USD conversion rate is $241,08 per Moderna, Inc..

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.

Guides

Find out how to buy Moderna, Inc.

Getting started with crypto can feel overwhelming, but learning where and how to buy crypto is simpler than you might think. Kickstart your journey on the OKX mobile app, or right here on the web.

Dive in

Predict Moderna, Inc.’s prices

How much will Moderna, Inc. be worth over the next few years? Check out the community’s thoughts and make your predictions.

Forecast

View Moderna, Inc.’s price history

Track your Moderna, Inc.’s price history to monitor your holdings’ performance over time. You can easily view the open and close values, highs, lows, and trading volume using the table below.

Check it out

More to explore

Moderna, Inc. FAQ

Moderna, Inc. can offer strong returns, but is also subject to market volatility. Whether it’s a good investment depends on your risk tolerance, goals, and market conditions. Moderna, Inc.’s price can be influenced by various factors such as adoption, regulation, technological advancement, and overall market sentiment. Always do your own research before buying Moderna, Inc. and never buy more than you can afford to lose. This content is for informational purposes only and isn’t financial advice.

To buy Moderna, Inc. at a low price, monitor the market closely and use tools like price alerts and technical indicators to keep you updated on price trends. Always do your own research and use secure platforms. This content is for informational purposes only and isn’t financial advice.

Depending on where you’re located, you can use bank transfer, credit/debit card, or Peer-to-Peer. Read our guide on how to use these different payment methods to buy Moderna, Inc. xMRNA safely on a trusted exchange like OKX.

Currently, one Moderna, Inc. is worth 241.08. For answers and insight into Moderna, Inc.’s price action, you’re in the right place. Explore the latest Moderna, Inc. charts and trade responsibly with OKX.

To read this Moderna, Inc. price chart, hover over or click on the time period you want to view. Hover over the chart to view the corresponding price, displayed in your local currency.

Yes, Moderna, Inc.’s price is updated in real-time on our Moderna, Inc. price page. You can view the current price and historical price data here at all times.

Countries and regions differ on how digital assets transactions and holdings are taxed and how they view digital assets in general (money, property, commodity). In general, it is expected that you will pay capital gains tax when selling or swapping Moderna, Inc. xMRNA. Refer here for a more detailed guide.

Staking and earning rewards with Moderna, Inc. are subject to local restrictions. Log in or sign up to view products available in your country, region, or state of residence.

ESG Disclosure

ESG (Environmental, Social, and Governance) regulations for crypto assets aim to address their environmental impact (e.g., energy-intensive mining), promote transparency, and ensure ethical governance practices to align the crypto industry with broader sustainability and societal goals. These regulations encourage compliance with standards that mitigate risks and foster trust in digital assets.
Read more